The First Case of Acute Lymphoblastic Leukemia With the E19a2 BCR–ABL1 Transcript: Imatinib Therapy Followed by Unrelated Donor Transplantation Induces a Durable Molecular Response

Leukemia - United Kingdom
doi 10.1038/leu.2010.265
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BCR/ABL1 -Like Acute Lymphoblastic Leukemia: How to Diagnose and Treat?

Cancer
Cancer ResearchOncology
2018English

Γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia

Cancer Cell
Cancer ResearchOncologyCell Biology
2019English

Tyrosine Kinase Fusion Genes in Pediatric BCR-ABL1-like Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2016English

Expression Profiling of Adult Acute Lymphoblastic Leukemia Identifies a BCR-ABL1-like Subgroup Characterized by High Non-Response and Relapse Rates

Haematologica
Hematology
2015English

A Novel BCR-ABL1 Mutation in a Patient With Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia

OncoTargets and Therapy
OncologyPharmacology
2018English

CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia Patients

Clinical Cancer Research
Cancer ResearchOncology
2011English

A Patient With Philadelphia-Negative Acute Lymphoblastic Leukemia With a FISH-Negative Cryptic BCR-ABL1 Rearrangement Detected by PCR and Sequencing Analysis

Hematology & Transfusion International Journal
2015English

BCR-ABL1 Mutations in Patients With Imatinib-Resistant Philadelphia Chromosome-Positive Leukemia by Use of the PCR-Invader Assay

Leukemia Research
Cancer ResearchOncologyHematology
2011English

Unrelated Donor Marrow Transplantation for Acute Myeloid Leukemia: An Update of the Seattle Experience

Bone Marrow Transplantation
TransplantationHematology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy